Could medical cannabis be a growth engine for the pharmaceutical industry? A subsidiary of Danish pharmaceutical giant Novo Nordisk is betting the answer is yes. NNE A/S, a 1,000-person strong pharmaceutical engineering and advisory unit of Novo Nordisk A/S , has been counselling medical cannabis companies on establishing pharmaceutical-grade facilities in Europe and Asia. NNE’s cannabis
Tips for entering Europe’s medical cannabis market: Q&A with Christian Carlsen of Danish pharma firm NNE is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
[Read More ...]
Originally posted on Tips for entering Europe’s medical cannabis market: Q&A with Christian Carlsen of Danish pharma firm NNE via George Scorsis Medical Marijuana News
No comments:
Post a Comment